Discontinued — last reported Q4 '19
Products & Services · Maximum Potential Milestone Payment To Be Made
Treprostinil — Maximum Potential Milestone Payment To Be Made
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ1 2019
Last reportedQ4 2019
How to read this metric
An increase indicates higher potential future cash outflows tied to successful product advancement, while a decrease suggests either the completion of milestones or a reduction in contractual obligations.
Detailed definition
This metric represents the aggregate future financial obligations contingent upon the successful achievement of specific...
Peer comparison
Commonly reported as contingent consideration or milestone obligations in pharmaceutical licensing agreements across the biotech industry.
Metric ID:
uthr_segment_treprostinil_maximum_potential_milestone_payment_to_be_madeSimilar Metrics at Other Companies
Frequently Asked Questions
- What does treprostinil — maximum potential milestone payment to be made mean?
- The total amount of future payments the company may owe if specific development or sales goals for a product are met.